|
|
| | 6-Benzothiazolesulfonamide, 2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimidinyl]amino]propyl]amino]- Basic information |
| | 6-Benzothiazolesulfonamide, 2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimidinyl]amino]propyl]amino]- Chemical Properties |
| Boiling point | 687.9±65.0 °C(Predicted) | | density | 1.48±0.1 g/cm3(Predicted) | | pka | 9.89±0.30(Predicted) |
| | 6-Benzothiazolesulfonamide, 2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimidinyl]amino]propyl]amino]- Usage And Synthesis |
| Uses | PCSK9-IN-16 is a potent PCSK9 inhibitor. PCSK9-IN-16 is extracted from patent WO2020150474, example 87, has the potential for hypercholesterolemia and other cardiovascular diseases research[1]. | | References | [1] Michael H, et al. Pcsk9 inhibitors and methods of use thereof. Patent WO2020150474 |
| | 6-Benzothiazolesulfonamide, 2-[[(2S)-2-methyl-3-[[5-(methylthio)-2-pyrimidinyl]amino]propyl]amino]- Preparation Products And Raw materials |
|